45.8%) but did not reach statistical significance ( p = 0.068).
← all excerpts
Age-Adjusted Charlson Comorbidity Index Guides Risk Stratification for Hepatocellular Carcinoma Patients Treated with TACE Combined with Immune Checkpoint Inhibitors and Targeted Therapy: A Multicenter Retrospective Cohort Study.
1
0.0680
0.0680